Assessment of patients' knowledge of their treatment with capecitabine at the National Institute of Oncology in Rabat.

Chaimaa Nouibi Ali Cherif ChefchaouniHafsa BecharMohammed Jaouad BelahcenYounes Rahali

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Capecitabine is an oral treatment of choice for colorectal and breast cancer in Morocco. Therapeutic education happens to be an effective tool in order to guarantee the best effectiveness and manage the possible side effects that can occur during the treatment.

Keyphrases

healthcare
randomized controlled trial
end stage renal disease
systematic review
squamous cell carcinoma
quality improvement
ejection fraction
young adults
peritoneal dialysis
locally advanced
study protocol
patient reported outcomes
phase iii
placebo controlled